Bristol-Myers Squibb Co (NYSE:BMY) shares, rose in value, with the stock price down by -0.02% to the previous day’s close as strong demand from buyers drove the stock to $58.89.
Actively observing the price movement in the recent trading, the stock is buoying the session at $58.90, falling within a range of $58.23 and $59.49. The value of beta (5-year monthly) is 0.436. Referring to stock’s 52-week performance, its high was $63.33, and the low was $39.35. On the whole, BMY has fluctuated by 0.15% over the past month.
With the market capitalization of Bristol-Myers Squibb Co currently standing at about $119.83 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-05. The company’s Forward Dividend Ratio is 2.42, with its dividend yield at 4.11%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 45.72B, with a low estimate of 10.01B and a high estimate of 11.3B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 10.77B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that BMY’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of BMY currently trading nearly -2.08% and 0.55% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 47.29, while the 7-day volatility ratio is showing 2.37% which for the 30-day chart, stands at 2.52%. Furthermore, Bristol-Myers Squibb Co (BMY)’s beta value is 0.43, and its average true range (ATR) is 1.45.
A comparison of Bristol-Myers Squibb Co (BMY) with its peers suggests the former has fared considerably weaker in the market. BMY showed an intraday change of -0.02% in today’s session so far, and over the past year, it grew by 12.06%%.
Data on historical trading for Bristol-Myers Squibb Co (NYSE:BMY) indicates that the trading volumes over the past 10 days have averaged 12.12 and over the past 3 months, they’ve averaged 11.54 million. According to company’s latest data on outstanding shares, there are 2.03 billion shares outstanding.
Nearly 0.08% of Bristol-Myers Squibb Co’s shares belong to company insiders and institutional investors own 79.94% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 37.01 million shares as on 2025-03-14, resulting in a short ratio of 2.91. According to the data, the short interest in Bristol-Myers Squibb Co (BMY) stood at 183.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 25.59 million. The stock has risen by 4.12% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the BMY stock heading into the next quarter.
